BACKGROUND: Platelet additive solutions (PASs) facilitate improved recovery of plasma and may reduce the severity and/or frequency of plasma‐associated transfusion reactions. Current apheresis platelet (PLT) PAS products contain approximately 30 to 40% residual plasma. In an effort to further decrease the residual plasma, two in vitro studies were conducted with PLTs suspended in 5% plasma and a reformulated PAS‐3, named PAS‐5, that contains additional salts, glucose, and bicarbonate.STUDY DESIGN AND METHODS: In Study 1, PLTs suspended in 5% plasma/95% PAS‐5 were prepared directly on a separator (Amicus, Fenwal, Inc.) without additional centrifugation or washing. In Study 2, a double unit of hyperconcentrated Amicus PLTs in plasma was collected, divided, and centrifuged to prepare a control unit in 100% plasma and a paired test unit in 5% plasma/95% PAS‐5. The in vitro properties of PLTs were assessed in both studies during 7‐day storage at 20 to 24°C with continuous agitation.RESULTS: In Study 1, PLT concentration, pH, mean PLT volume (MPV), HCO3‐, pCO2, pO2, lactate dehydrogenase, and hypotonic shock response (HSR) did not significantly change during storage. By Day 7, glucose levels and morphology scores modestly decreased (17.6 and 14.4%, respectively) and lactate levels modestly increased (to 7.2 mmol/L). In Study 2, MPV, pH, glucose, pO2, HSR, and morphology were comparable in control and test PLTs during 7‐day storage. Glucose consumption and lactate production were significantly less in test versus control PLTs (p ≤ 0.0015). Extent of shape change and %CD62P‐positive test PLTs were less than those of controls (p < 0.001).CONCLUSION: Apheresis PLTs suspended in 5% plasma/95% PAS‐5 maintained in vitro properties during 7‐day storage.